Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioAge Labs (BIOA) Invested Capital (2023 - 2026)

BioAge Labs' Invested Capital history spans 3 years, with the latest figure at $274.1 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 16.73% to $274.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $274.1 million, a 16.73% decrease, with the full-year FY2025 number at $274.1 million, down 16.73% from a year prior.
  • Invested Capital hit $274.1 million in Q4 2025 for BioAge Labs, down from $281.0 million in the prior quarter.
  • Over the last five years, Invested Capital for BIOA hit a ceiling of $329.1 million in Q4 2024 and a floor of -$197.1 million in Q2 2024.
  • Historically, Invested Capital has averaged $141.4 million across 3 years, with a median of $281.0 million in 2025.
  • Biggest five-year swings in Invested Capital: surged 296.62% in 2024 and later fell 16.73% in 2025.
  • Tracing BIOA's Invested Capital over 3 years: stood at -$167.4 million in 2023, then surged by 296.62% to $329.1 million in 2024, then decreased by 16.73% to $274.1 million in 2025.
  • Business Quant data shows Invested Capital for BIOA at $274.1 million in Q4 2025, $281.0 million in Q3 2025, and $299.8 million in Q2 2025.